RxDoctor Payments Data

Staci Sheba, DO

Family Medicine · Uniontown, PANPI 1538133871

Payments from drug & device makers

$17,237in general payments, 2019–2025

Across 1,094 payments — averaging $15.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AstraZeneca$1K
  • AbbVie$1K
  • GSK$1K
  • Pfizer$1K
  • Lilly USA, LLC$1K
  • plus $9K from 53 others

What the payments were for

  • Food & beverage$17,201100%
  • Education$360%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk126$1,979
AstraZeneca71$1,454
AbbVie(2 entities)136$1,442
GSK92$1,394
Pfizer84$1,330
Lilly USA, LLC73$1,099
Boehringer Ingelheim66$933
Johnson & Johnson68$863
Amgen(2 entities)38$691
Bayer30$545
Exact Sciences23$505
Amarin Pharma, Inc.25$420
Sanofi-aventis U.S. LLC31$406
E.r. Squibb & Sons, L.L.C.22$385
Novartis26$378
Otsuka America Pharmaceutical, Inc.18$310
Abbott15$268
Idorsia Pharmaceuticals US Inc12$194
Esperion Therapeutics, Inc.12$191
Biohaven Pharmaceutical Holding Company Ltd.10$180
Takeda Pharmaceuticals U.S.A., Inc.10$179
Kowa Pharmaceuticals America, Inc.10$162
Astellas Pharma US Inc9$157
Vanda Pharmaceuticals Inc.5$131
Radius Health, Inc.1$125
Daiichi Sankyo Inc.6$123
Merck7$117
Dexcom, Inc.8$116
Phathom Pharmaceuticals, Inc.5$115
Genentech USA, Inc.4$78
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$74
Madrigal Pharmaceuticals2$69
Ardelyx, Inc.3$67
Akcea Therapeutics, Inc.4$66
Eisai Inc.3$59
Gilead3$40
Tactile Systems Technology Inc2$39
Teva Pharmaceuticals USA, Inc.3$38
Regeneron Healthcare Solutions, Inc.1$38
Xeris Pharmaceuticals, Inc.2$38
Lundbeck LLC1$33
ARS Pharmaceuticals Operations, Inc.2$31
Avanir Pharmaceuticals, Inc.2$30
Vericel Corporation1$30
Redhill Biopharma Inc.2$29
Sunovion Pharmaceuticals Inc.2$29
Biohaven Pharmaceuticals, Inc.2$28
Sanofi1$28
Amneal Pharmaceuticals LLC1$26
Actelion Pharmaceuticals US, Inc.1$23
Boston Scientific1$19
Aimmune Therapeutics, Inc.1$18
Axsome Therapeutics, Inc.1$18
Insulet Corporation1$18
Harmony Biosciences LLC1$17
Shield Therapeutics Inc1$17
Currax Pharmaceuticals LLC1$16
Sun Pharmaceutical Industries Inc.1$16
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,237 in reported general payments places this provider in the 95th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$93,518
Medicare patients
301
Services billed
1,286

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban196$176,189
OzempicSemaglutide138$161,360
TrulicityDulaglutide118$140,649
MounjaroTirzepatide112$127,156
JardianceEmpagliflozin147$125,715
FarxigaDapagliflozin Propanediol55$48,903
TradjentaLinagliptin48$43,815
RybelsusSemaglutide37$43,233
XareltoRivaroxaban45$35,278
JanuviaSitagliptin Phosphate30$29,441
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog40$28,269
Breo ElliptaFluticasone/Vilanterol46$27,823
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$18,756
LinzessLinaclotide21$16,027
MyrbetriqMirabegron21$15,585

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$1,099$267,805230 claims
Novo NordiskOzempic, Rybelsus$1,979$204,593175 claims
PfizerEliquis$1,330$176,189196 claims
Boehringer IngelheimJardiance, Tradjenta$933$169,529195 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,454$62,18769 claims
GSKBreo Ellipta, Trelegy Ellipta$1,394$46,57968 claims
MerckJanuvia, Janumet$117$42,01748 claims
Johnson & JohnsonXarelto$863$35,27845 claims
AbbVieLinzess, Synthroid$1,442$19,63075 claims
Astellas Pharma US IncMyrbetriq$157$15,58521 claims
NovartisEntresto$378$11,49812 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$26$6,558587 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Uniontown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →